Pharmaceuticals news continually updated from thousands of sources around the net.
14 hrs ago | Forbes.com
Market capitalization is an important data point for investors to keep an eye on, for various reasons.
Trending on the Topix Network
Omega-3-Acid Ethyl Esters Capsules, USP, Marketed by: Teva Pharmaceutical Industries Ltd Compare to: Lovaza Indication: Teva Pharmaceutical Industries Ltd announces the approval of Omega-3-Acid Ethyl Esters Capsules, USP, a generic equivalent to GlaxoSmithKline's Lovaza.
Reuters reports that generic drug firm Mylan is in advanced negotiations with Abbott Laboratories to purchase a multibillion dollar portfolio of its established off-patent Europe-based drugs.
In its July 9, 2014 weekly enforcement report, FDA reported three voluntary drug product recalls from three different manufacturers due to dissolution problems.
Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.
India's Sun Pharmaceutical Industries Ltd is recalling 41,127 bottles of antidepressant venlafaxine hydrochloride in the United States after the drug failed to dissolve properly, the U.S. Food and Drug Administration said.
The Ghana Chamber of Pharmacy has said it will not be able to supply medicines and medical consumables to health institutions that are in arrears beyond two months.
The financ... )--E2open, Inc. , the leading provider of strategic, cloud-based software solutions for collaborative planning and execution across global trading n... )--Artisan Partners Asset Management Inc. today reported that its assets under management as of June 30, 2014 totaled $112.0 billion.
Takeda Pharmaceutical Company Limited and its partner, Zinfandel Pharmaceuticals, Inc. , will present data during multiple poster and oral sessions at the upcoming Alzheimer's Association International ConferenceA 2014 , taking place in "Studies show that individuals with mild cognitive impairmenta slight, although noticeable and measurable decline ... (more)
Teva Pharmaceutical Industries Ltd has earned an average rating of "Buy" from the twenty-four analysts that are presently covering the company, AnalystRatingsNetwork reports .
Bristol-Myers Squibb Company today announced that, following discussions with the U.S. Food and Drug Administration , the company is planning a third quarter submission of a Biologics Licensing Application for OpdivoA for previously treated advanced melanoma.
Raptor Pharmaceutical Corp. Director Llew Keltner sold 10,000 shares of the stock in a transaction that occurred on Monday, July 7th.
"Our business model is driven by a broad portfolio of strong brand, generic and OTC products, a commitment to development-focused, results oriented research and development and the size and scale needed to efficiently and cost-effectively meet the needs of our global customer base.
Les Laboratoires Servier and five makers of generic drugs, including Teva Pharmaceutical Industries Ltd., were fined 427.7 million euros by the European Union over agreements that delayed the release of cheaper versions of a hypertension treatment.
European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others a total of 428 million euros on Wednesday for blocking cheaper generic medicine.
Updated: Sat Jul 12, 2014 06:56 am
Copyright © 2014 Topix LLC